Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Significance of Metformin Use in Diabetic Kidney Disease
Daiji Kawanami, Yuichi Takashi, Makito Tanabe
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4239-4239
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice
Elisa Gremese, Dario Bruno, Valentina Varriano, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 6017-6017
Open Access | Times Cited: 49
Nrf2 Pathway and Oxidative Stress as a Common Target for Treatment of Diabetes and Its Comorbidities
Michelle Yi, L Cisneros, E.J. Cho, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 821-821
Open Access | Times Cited: 18
The Current and Potential Therapeutic Use of Metformin—The Good Old Drug
Józef Drzewoski, M Hanefeld
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 122-122
Open Access | Times Cited: 101
Metformin: A Novel Weapon Against Inflammation
Bo Bai, Haibo Chen
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 97
Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosis
Zhaoxian Cai, Xiaotian Wu, Zijun Song, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives
Yu Wang, Mingyue Jin, Chak Kwong Cheng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 33
Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes
Ehsan Sayedali, Ali Erdinç Yalın, Serap Yalın
World Journal of Diabetes (2023) Vol. 14, Iss. 5, pp. 585-593
Open Access | Times Cited: 25
The Role and Mechanism of Metformin in Inflammatory Diseases
Huan Lin, Haiyong Ao, Guang‐hua Guo, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 5545-5564
Open Access | Times Cited: 22
Fucoidan Improves Early Stage Diabetic Nephropathy via the Gut Microbiota–Mitochondria Axis in High-Fat Diet-Induced Diabetic Mice
Zhaoyi Zhong, Yangting Zhang, Wei Yuan, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 17, pp. 9755-9767
Closed Access | Times Cited: 9
NETosis: an emerging therapeutic target in renal diseases
Márk Juha, Adél Molnár, Zoltán Jakus, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Metformin Is Associated with the Inhibition of Renal Artery AT1R/ET-1/iNOS Axis in a Rat Model of Diabetic Nephropathy with Suppression of Inflammation and Oxidative Stress and Kidney Injury
Amal F. Dawood, Amro Maarouf, Norah M. Alzamil, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1644-1644
Open Access | Times Cited: 24
The role and mechanism of the gut microbiota in the development and treatment of diabetic kidney disease
Xiaofang Wu, Lei Zhao, Yújiāng Zhāng, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 15
Metformin Attenuates the Inflammatory Response via the Regulation of Synovial M1 Macrophage in Osteoarthritis
Meng Zheng, Yuanli Zhu, Kang Wei, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5355-5355
Open Access | Times Cited: 12
Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect
Raphaëlle Corremans, Benjamin A. Vervaet, Geert Dams, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9043-9043
Open Access | Times Cited: 11
The effect of Argania spinosa seed oil on diabetic nephropathy in streptozotocin-induced diabetes in Wistar rats
Nour Elhouda Daoudi, Soufiane El Assri, Mohammed Aziz, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 118083-118083
Closed Access | Times Cited: 4
Saracatinib, a Src kinase inhibitor, enhances the renoprotective effect of metformin and losartan in diabetic nephropathy
Suzan A Khodir, Eman Sweed, Mona A. Kora, et al.
Archives of Physiology and Biochemistry (2025), pp. 1-16
Closed Access
Diabetes and Its Complications: Therapies Available, Anticipated and Aspired
Anu Grover, Komal Sharma, Suresh Gautam, et al.
Current Diabetes Reviews (2020) Vol. 17, Iss. 4, pp. 397-420
Closed Access | Times Cited: 30
Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study
Randa Farah, Mohammed Qussay Al-Sabbagh, Munther Momani, et al.
BMC Nephrology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Metformin Improves the Senescence of Renal Tubular Epithelial Cells in a High-Glucose State Through E2F1
Dan Liang, Zhiyang Li, Zhaowei Feng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
To target cellular senescence in diabetic kidney disease: the known and the unknown
Yuehan Wei, Shan Mou, Qing Yang, et al.
Clinical Science (2024) Vol. 138, Iss. 16, pp. 991-1007
Open Access | Times Cited: 3
Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho/TGF-β1/p38MAPK signaling pathway
Li-Yuan Gu, Yun-Sun, Haitao Tang, et al.
Journal of Ethnopharmacology (2020) Vol. 281, pp. 113548-113548
Closed Access | Times Cited: 27
Metformin ameliorates bladder dysfunction in a rat model of partial bladder outlet obstruction
Lipeng Chen, Linchen Lv, Lekai Zhang, et al.
AJP Renal Physiology (2021) Vol. 320, Iss. 5, pp. F838-F858
Closed Access | Times Cited: 20
Management of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia
Marcus D. Goncalves, Azeez Farooki
Integrative Cancer Therapies (2022) Vol. 21
Open Access | Times Cited: 14
Kidney-Targeted Drug Delivery System Based on Metformin-Grafted Chitosan for Renal Fibrosis Therapy
Haihan Sun, Kun Shi, Bangjie Zuo, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 9, pp. 3075-3084
Closed Access | Times Cited: 13
Canagliflozin ameliorates high glucose-induced apoptosis in NRK-52E cells via inhibiting oxidative stress and activating AMPK/mTOR-mediated autophagy
Hong Liu, Weidong Chen, Sheng Wan, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 12, pp. 10325-10337
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top